Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Microfluidics Files for Patent on Microfluidics Reaction Technology (MRT)

Abstract:
Microfluidics has filed for a patent on its Microfluidics Reaction Technology (MRT), which will enable companies and research organizations to develop and manufacture smaller-sized nanoparticles than previously possible and to do so more efficiently than with other methods. MRT was presented at the Nano Science and Technology Institute (NSTI) Nanotech 2007 and 2008 conferences and won a Nano 50™ award in 2007 as one of the most innovative ideas that will revolutionize nanotechnology in the near-term and beyond.

Microfluidics Files for Patent on Microfluidics Reaction Technology (MRT)

Newton, MA | Posted on January 16th, 2009

The patent covers processors, processes, and applications that are used to produce nanoparticles at high volume, high purity, and low cost. MRT can also be used for synthesis of fine chemicals through single or multiphase chemical reactions or physical processes such as crystallization. Another key use is process intensification, or combining chemical processes in ways that increase manufacturing efficiency, reduce energy use, and result in purer products.

MRT has a wide range of applications, including production of pharmaceutical nanosuspensions and of nanomaterials that are used for fuel cells and photovoltaics. It is particularly applicable for those pharmaceutical applications where the trend is to go to very small particles that have precise polymorph control. Microfluidics has demonstrated MRT by creating nanosuspensions of a variety of injectable or inhalable drugs, including cancer therapies, antibiotics, antihistamines, and non-steroidal anti-inflammatories, among others. "We used solvent/anti-solvent crystallization, precipitation, or chemical reactions to create these nanosuspensions," says Dr. Thomai "Mimi" Panagiotou, Microfluidics' Chief Technology Officer. "We were also able to encapsulate drugs in polymers using the same technique."

At the core of MRT is a continuous impinging jet microreactor (reaction chamber) with flow rates in liters or tens of liters per minute, capable of mixing the reactants at the nanometer level. The flow velocities inside the reaction chamber are orders of magnitude higher than that of existing impinging jet designs. Particles are built up molecule by molecule in fractions of a second. The process results in extreme purity of products and creates smaller particles than those ever before achieved.

Dr. Panagiotou noted "Most technologies that produce nanomaterials rely on ‘top down' approaches, i.e. breaking large particles into smaller particles. MRT creates nanoparticles from the ‘bottom up.' This is a more efficient approach and it can create smaller particles than ‘top down' methods. Crystals can be made to a targeted size range with no need for additional micronization, instead of making them and then breaking them down to the desired size."

####

About Microfluidics
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid-processing equipment and reaction technology for laboratory, pilot-scale, and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products, and produces the most uniform and smallest liquid and suspended solid particles available.

Microfluidics has been a worldwide supplier of Microfluidizer® high-shear fluid- processing systems to the biotechnology, pharmaceutical, chemical and cosmetics industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate, and produce licensed drugs for the worldwide healthcare market.

Companies seeking to produce difficult-to-formulate products or to find better methods of bioprocessing can take advantage of complimentary sample testing at any of three Microfluidics facilities. Visit www.microfluidicscorp.com, email or contact Microfluidics at 800.370.5452 for application information.

For more information, please click here

Contacts:
Katie DePorter
Gray & Rice Public Relations
617.367.0100 ext. 121

Copyright © Microfluidics International Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

NanoTechnology for Defense (NT4D) October 22nd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Microfluidics/Nanofluidics

Dolomite and Lab on a Chip launch Productizing Science® Competition 2015 October 7th, 2014

Dolomite to launch Meros TCU-100 temperature controller at Lab-on-a-Chip & Microarray World Congress September 15th, 2014

First Colloid and Polymer Science Lecture awarded to Orlin D. Velev: Chemical engineer honored for outstanding research in colloid science September 12th, 2014

UO-Berkeley Lab unveil new nano-sized synthetic scaffolding technique: Oil-and-water approach from Richmond's UO lab to spark new line of versatile peptoid nanosheets September 2nd, 2014

Announcements

NanoTechnology for Defense (NT4D) October 22nd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Patents/IP/Tech Transfer/Licensing

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE